The team of Motoyama in Kumamoto has recently published new results on folate-appended CDs in leukemia and ovarian cancer (1,2).
A patent application by Knut M. Wittkowski (ASDERA LLC, US) entitled “Use of cyclodextrins in diseases and disorders involving phospholipid
A novel folate receptor-targeted β-cyclodextrin drug delivery vehicle was constructed to improve the bioavailability, biosafety, and drug loading capacity of
Wan et al. (2021) published on the synthesis and potential utilization of β-CD modified with hyperbranced polyglycerol polymer and decorated
The antibacterial activity of triazole functionalized cyclodextrin (CD.Click) and cyclodextrin-triazole-titanium based nanocomposite (CD.COM) was evaluated. The results indicated that CD.Click
Cytokines are key components of the immune system and play pivotal roles in anticancer immune response. Cytokines as either therapeutic
The malignancy of colorectal cancer is connected with inflammation and tumor-associated macrophages (TAMs), but effective therapeutics for colorectal cancer are
Water-soluble seven hexylimidazolium modified amphiphilic cyclodextrin (AMCD) selectively combined with ATP to form a stable 1 : 1 inclusion complex
2021 China International BioPharma Conference will be held on September 19th-21th in China Medical City Convention and Exhibition Center, Taizhou China.
Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company shared top-line final data from its phase I study of Cantrixil (TRX-E-002-1)